| Name | (3R,4R,5R)-2-methoxy-3,4-bis(phenylmethoxy)-5-(phenylmethoxymethyl)oxolane | 
|---|---|
| Synonyms | 
                                
                                2,3,5-tri-O-benzyl-1-O-methyl-D-ribose
                                
                                
                                 Methyl 2,3,5-tri-O-benzyl-D-ribofuranoside methyl 2,3,4-tri-O-benzylribofuranoside methyl-2,3,5-tri-O-benzyl-D-riboside D-Ribofuranoside, methyl 2,3,5-tris-O-(phenylmethyl)- methyl tri-O-benzyl-D-ribofuranoside  | 
                        
| Description | Methyl 2,3,5-tri-O-benzyl-D-ribofuranoside is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | 
|---|---|
| Related Catalog | |
| References | 
| Density | 1.2±0.1 g/cm3 | 
|---|---|
| Boiling Point | 552.6±50.0 °C at 760 mmHg | 
| Molecular Formula | C27H30O5 | 
| Molecular Weight | 434.52 | 
| Flash Point | 217.4±30.0 °C | 
| Exact Mass | 434.209320 | 
| PSA | 46.15000 | 
| LogP | 6.48 | 
| Vapour Pressure | 0.0±1.4 mmHg at 25°C | 
| Index of Refraction | 1.587 | 
| Precursor 0 | |
|---|---|
| DownStream 2 | |